Related Experiment Video
Updated: Jul 4, 2025

11:02
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
539
MetDIT: Transforming and Analyzing Clinical Metabolomics Data with Convolutional Neural Networks
Yuyang Sha1, Weiyu Meng1, Gang Luo1
1Center for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macau SR 999708, China.
Analytical Chemistry
|February 7, 2024
Summary
MetDIT, a novel deep learning method, effectively analyzes complex clinical metabolomics data. It transforms data into images for convolutional neural networks, outperforming traditional machine learning in precision medicine applications.
Area of Science:
- Computational biology
- Bioinformatics
- Machine learning
Background:
- Clinical metabolomics is crucial for precision medicine.
- Classical machine learning methods face challenges with high-dimensional, complex metabolomics data.
Purpose of the Study:
- Introduce MetDIT, a deep learning method for analyzing intricate metabolomics data.
- Enhance the classification performance of metabolomics data analysis.
Main Methods:
- Developed TransOmics to convert 1D sequence data into 2D images for CNN compatibility.
- Utilized NetOmics with a CNN architecture to extract discriminative features.
- Implemented a feature augmentation module (FAM) and a specialized loss function to address overfitting and class imbalance.
- Optimized model backbone and image resolution for efficiency.
Main Results:
- MetDIT demonstrated superior classification performance on three clinical metabolomics datasets.
- Outperformed established machine learning methods like Random Forest, SVM, XGBoost, and LightGBM.
- The method effectively handles high dimensionality and complex intercorrelations in metabolomics data.
Conclusions:
- MetDIT offers a powerful new approach for clinical metabolomics data analysis.
- The deep learning framework provides enhanced precision medicine insights.
- Source code and a WebApp are available for broader accessibility and application.

